PacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it is bringing together a group of scientific experts to form PacBio's Scientific Advisory Board (SAB)
World Class Team Will Provide Strategic Guidance and Direction for PacBio's Research and Development Activities
MENLO PARK, Calif., Nov. 2, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it is bringing together a group of scientific experts to form PacBio's Scientific Advisory Board (SAB). The SAB will provide guidance to the research and development efforts at PacBio, including critical feedback, advice, and expertise on future technological and scientific direction to inform PacBio's priorities and roadmaps for current and future products. The goal of the SAB is to help provide a strong voice for the future of the 'omics and quantitative biology fields, while advocating for ways PacBio can create that future.
SAB members were chosen based on their leadership in fields such as biophysics, genomics, medicine, biology, chemistry and/or chip fabrication. The SAB will be made up initially of the following individuals:
